Multi-Center Study: The Biochemical Efficacy, Safety and Tolerability of a New α1-Proteinase Inhibitor, Zemaira-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multi-Center Study: The Biochemical Efficacy, Safety and Tolerability of a New α1-Proteinase Inhibitor, Zemaira

Published:2006-01 Issue:1 Volume:3 Page:17-23
ISSN:1541-2555
Container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease

Author:

Stocks James M.,Brantly Mark,Pollock David,Barker Alan,Kueppers Friedrich,Strange Charlie,Donohue James F.,Sandhaus Robert

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/15412550500493220

Reference18 articles.

1. Pulmonary Emphysema and Alpha1-Antitrypsin Deficiency

2. Alpha1-Antitrypsin Deficiency

3. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

4. Clinical Features and Natural History of Severe α1-Antitrypsin Deficiency

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Alpha-1 Antitrypsin–Fc Fusion Protein INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency: A Phase 1 Study;Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation;2024

2. Evaluation of body weight–based dosing, alternative dosing regimens, and treatment interruptions for α1-proteinase inhibitors and implications on biochemical efficacy in patients with α1-antitrypsin deficiency;Pulmonary Pharmacology & Therapeutics;2023-12

3. Atteinte pulmonaire du déficit en alpha-1 antitrypsine. Recommandations pratiques pour le diagnostic et la prise en charge;Revue des Maladies Respiratoires;2022-09

4. Pharmacokinetics and Biochemical Efficacy of an α1-Proteinase Inhibitor (Aralast NP) in α1-Antitrypsin Deficiency: a Cross-Product Retrospective Comparability Analysis;Pulmonary Therapy;2022-08-24

5. Alpha-1 antitrypsin deficiency and recombinant protein sources with focus on plant sources: Updates, challenges and perspectives;Free Radical Biology and Medicine;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3